159 related articles for article (PubMed ID: 25193236)
1. LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis.
Han Y; Xue X; Jiang M; Guo X; Li P; Liu F; Yuan B; Shen Y; Guo X; Zhi Q; Zhao H
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):267-73. PubMed ID: 25193236
[TBL] [Abstract][Full Text] [Related]
2. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.
Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z
BMC Cancer; 2015 Dec; 15():948. PubMed ID: 26674601
[TBL] [Abstract][Full Text] [Related]
3. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.
Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z
BMC Cancer; 2016 Jan; 16():12. PubMed ID: 26758198
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of LGR5 in colorectal cancer: a meta-analysis.
Chen Q; Zhang X; Li WM; Ji YQ; Cao HZ; Zheng P
PLoS One; 2014; 9(9):e107013. PubMed ID: 25192390
[TBL] [Abstract][Full Text] [Related]
5. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.
Wu XS; Xi HQ; Chen L
World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436
[TBL] [Abstract][Full Text] [Related]
6. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
[TBL] [Abstract][Full Text] [Related]
7. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
8. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
[No Abstract] [Full Text] [Related]
9. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
[TBL] [Abstract][Full Text] [Related]
11. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
12. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
Valladares-Ayerbes M; Blanco-Calvo M; Reboredo M; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Díaz-Prado S; Medina V; Santamarina I; Pértega S; Figueroa A; Antón-Aparicio LM
Int J Mol Sci; 2012; 13(4):4367-4387. PubMed ID: 22605983
[TBL] [Abstract][Full Text] [Related]
14. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer.
Kleist B; Xu L; Li G; Kersten C
Int J Clin Exp Pathol; 2011 Apr; 4(4):327-35. PubMed ID: 21577318
[TBL] [Abstract][Full Text] [Related]
15. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
16. Expression Profile of LGR5 and Its Prognostic Significance in Colorectal Cancer Progression.
Jang BG; Kim HS; Chang WY; Bae JM; Kim WH; Kang GH
Am J Pathol; 2018 Oct; 188(10):2236-2250. PubMed ID: 30036518
[TBL] [Abstract][Full Text] [Related]
17. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
Kang XL; He LR; Chen YL; Wang SB
World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of Leucine-rich repeat-containing G-protein-coupled receptor 5 in gastric cancer: A systematic review with meta-analysis.
Huang T; Qiu X; Xiao J; Wang Q; Wang Y; Zhang Y; Bai D
Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):246-53. PubMed ID: 26387842
[TBL] [Abstract][Full Text] [Related]
19. Lgr5 Contributes to Intestinal Metaplasia During Gastric Carcinogenesis: A Meta analysis.
Han Y; Zhi Q; Xue X; Yuan B; Zhao H; Kuang Y; Zhang L
Anticancer Agents Med Chem; 2016; 16(9):1079-84. PubMed ID: 26077638
[TBL] [Abstract][Full Text] [Related]
20. CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis.
Wang JL; Su WY; Lin YW; Xiong H; Chen YX; Xu J; Fang JY
Oncotarget; 2017 Feb; 8(8):12866-12876. PubMed ID: 28030817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
